Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$941M |
| 2 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$933M |
| 3 |
Dimensional Emerging Markets High Profitability ETF
DEHP
|
+$467M |
| 4 |
Exxon Mobil
XOM
|
+$386M |
| 5 |
Warner Bros
WBD
|
+$260M |
Top Sells
| 1 |
Dimensional National Municipal Bond ETF
DFNM
|
+$654M |
| 2 |
AT&T
T
|
+$372M |
| 3 |
Amazon
AMZN
|
+$350M |
| 4 |
Dimensional US High Profitability ETF
DUHP
|
+$263M |
| 5 |
CERN
Cerner Corp
CERN
|
+$212M |
Sector Composition
| 1 | Financials | 16.93% |
| 2 | Technology | 15.17% |
| 3 | Industrials | 11.99% |
| 4 | Healthcare | 11.63% |
| 5 | Consumer Discretionary | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
DURECT Corp
DRRX
$59.9M
| $126K | ﹤0.01% |
26,324
| – | – |
|
3302
QuickLogic
QUIK
$88.9M
| $126K | ﹤0.01% |
14,860
-7,800
| -34% | -$66.1K |
|
3303
CorMedix
CRMD
$973M
| $125K | ﹤0.01% |
30,991
+13,088
| +73% | +$52.8K |
|
3304
Team
TISI
$86.5M
| $125K | ﹤0.01% |
16,806
-12,726
| -43% | -$94.7K |
|
|
APEN
3305
DELISTED
Apollo Endosurgery, Inc.
APEN
| $125K | ﹤0.01% |
+34,327
| New | +$125K |
|
3306
MediciNova
MNOV
$62.8M
| $123K | ﹤0.01% |
48,674
-1,900
| -4% | -$4.8K |
|
3307
Taitron Components
TAIT
$16.7M
| $122K | ﹤0.01% |
33,564
+2,505
| +8% | +$9.11K |
|
3308
Denison Mines
DNN
$2.14B
| $121K | ﹤0.01% |
124,789
+87,780
| +237% | +$85.1K |
|
3309
Instil Bio
TIL
$172M
| $121K | ﹤0.01% |
+1,311
| New | +$121K |
|
3310
Flexible Solutions
FSI
$123M
| $120K | ﹤0.01% |
48,862
| – | – |
|
|
LGO
3311
Largo
LGO
$96.2M
| $120K | ﹤0.01% |
17,572
+7,038
| +67% | +$48.1K |
|
3312
Pliant Therapeutics
PLRX
$107M
| $118K | ﹤0.01% |
14,707
+1,224
| +9% | +$9.82K |
|
3313
DiaMedica Therapeutics
DMAC
$373M
| $117K | ﹤0.01% |
58,015
| – | – |
|
|
IMMP
3314
Immutep
IMMP
$235M
| $117K | ﹤0.01% |
57,835
+28,537
| +97% | +$57.7K |
|
3315
NovaGold Resources
NG
$2.74B
| $117K | ﹤0.01% |
24,400
| – | – |
|
3316
Comstock Holding Companies
CHCI
$165M
| $115K | ﹤0.01% |
25,592
| – | – |
|
3317
PDS Biotechnology
PDSB
$55.5M
| $114K | ﹤0.01% |
31,170
-38,458
| -55% | -$141K |
|
3318
Arts-Way Manufacturing Co
ARTW
$15.7M
| $111K | ﹤0.01% |
37,760
+23,253
| +160% | +$68.4K |
|
3319
Renovaro
RENB
$51.3M
| $111K | ﹤0.01% |
57,545
-8,886
| -13% | -$17.1K |
|
3320
MEI Pharma
MEIP
$91.3M
| $110K | ﹤0.01% |
9,099
-2,537
| -22% | -$30.7K |
|
|
SY
3321
So-Young International
SY
$411M
| $110K | ﹤0.01% |
128,511
+9,080
| +8% | +$7.77K |
|
|
EGLX
3322
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
| $109K | ﹤0.01% |
54,895
+38,383
| +232% | +$76.2K |
|
|
WIMI
3323
WiMi Hologram Cloud
WIMI
$41.6M
| $108K | ﹤0.01% |
+4,960
| New | +$108K |
|
3324
Leap Therapeutics
LPTX
$11.7M
| $107K | ﹤0.01% |
9,279
-5,356
| -37% | -$61.8K |
|
|
BCEL
3325
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $107K | ﹤0.01% |
59,927
-1,262
| -2% | -$2.25K |
|